ストックスクリーナーアプリを入手
39.37
0.76%
0.63
前日終値:
$38.74
開ける：
$38.9
24時間の取引高:
12,429
Relative Volume:
0.02
時価総額：
$1.94B
収益：
$3.53B
当期純損益:
$30.99M
株価収益率:
64.18
EPS:
0.6134
ネットキャッシュフロー:
$154.99M
1週間 パフォーマンス:
-4.35%
1か月 パフォーマンス:
-14.13%
6か月 パフォーマンス:
+96.56%
1年 パフォーマンス:
+30.25%
1日の値動き範囲:
$38.90
$39.16
1週間の範囲:
$38.52
$41.00
52週間の値動き範囲:
$18.08
$51.60
Astrana Health Inc Stock (ASTH) Company Profile
Compare ASTH vs HCA, THC, FMS, EHC, DVA
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ASTH
Astrana Health Inc
|
39.05 | 1.95B | 3.53B | 30.99M | 154.99M | 0.6134 |
HCA
Hca Healthcare Inc
|
414.38 | 88.13B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
274.36 | 21.62B | 21.46B | 2.65B | 3.35B | 19.23 |
FMS
Fresenius Medical Care Ag Adr
|
23.47 | 12.69B | 22.44B | 1.35B | 2.03B | 1.9002 |
EHC
Encompass Health Corp
|
121.03 | 12.01B | 6.07B | 793.80M | 464.40M | 5.9914 |
DVA
Davita Inc
|
175.51 | 11.31B | 13.84B | 1.10B | 1.49B | 10.42 |
Astrana Health Inc Stock (ASTH) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-12 | 開始されました | Needham | Buy |
| 2025-04-01 | 開始されました | Barclays | Equal Weight |
| 2024-10-14 | 開始されました | TD Cowen | Buy |
| 2024-10-11 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2024-07-11 | アップグレード | Truist | Hold → Buy |
| 2024-05-30 | 開始されました | Robert W. Baird | Outperform |
| 2024-02-26 | 開始されました | Jefferies | Buy |
| 2024-02-22 | アップグレード | BofA Securities | Neutral → Buy |
| 2024-01-24 | 開始されました | Stifel | Buy |
| 2023-12-22 | 開始されました | Truist | Hold |
| 2023-10-17 | 開始されました | BTIG Research | Buy |
| 2023-04-12 | 開始されました | BofA Securities | Neutral |
| 2022-12-19 | 開始されました | Lake Street | Buy |
| 2022-09-21 | 開始されました | William Blair | Outperform |
| 2022-01-11 | 再開されました | Colliers Securities | Buy |
| 2021-08-12 | 開始されました | Barclays | Equal Weight |
すべてを表示
Astrana Health Inc (ASTH) 最新ニュース
Astrana Health (ASTH) Shares Just Moved, So What Is Going On? - Sahm
Astrana Health Director David Schmidt Executes Option Exercise and Sells Shares via Issuer Repurchase - Kalkine Media
Astrana Health (NASDAQ: ASTH) director sells 20K shares back to company - Stock Titan
ASTH | Astrana Health Inc. Common FinancialsRevenue Breakdown - Quiver Quantitative
Astrana Health (NASDAQ:ASTH) Rating Lowered to Hold at Wall Street Zen - MarketBeat
Astrana Health (ASTH) Surges 7.99% to $40.81 — Key Levels to WatchHigh Beta Stocks - Vinanet
5 Must-Read Analyst Questions From Astrana Health’s Q2 Earnings Call - Yahoo Finance
Astrana Health Inc (ASTH) Shares Surge 8.2% -- What GF Score of 85 Tells Investors - GuruFocus
Astrana Health (NASDAQ:ASTH) Rally Puts Growth In Focus - Kalkine Media
Astrana Health Jumps 7.1% After Truist Securities Maintains Buy - AlphaStreet
Astrana Health (ASTH) Surges 7.57% as Healthcare Services Stock Breaks HigherLow Risk Entry Stocks - Vinanet
Astrana Health (NASDAQ:ASTH) Shares Up 7.9%Still a Buy? - MarketBeat
Astrana Health (ASTH) Is Up 10.7% After Raising 2026 Guidance And Doubling Q2 Net IncomeHas The Bull Case Changed? - simplywall.st
ASTH Q2 2026 Earnings: 16.7% EPS Beat Drives OptimismSaaS Earnings Trends - Vinanet
Astrana Health: 81% Full-Risk And Profitable (NASDAQ:ASTH) - Seeking Alpha
Is Astrana Health Inc (ASTH) a Bargain After 8.1% Drop? GF Value Says Undervalued - GuruFocus
Astrana Health (NASDAQ:ASTH) Stock Price Down 5.7%What's Next? - MarketBeat
ASTRANA HEALTH, INC. : TRUIST SECURITIES RAISES TARGET PRICE TO $55 FROM $47 - Bitget
EVOLENT HEALTH, INC. : CITIGROUP RAISES TO BUY FROM NEUTRAL; CUTS TARGET PRICE TO $6 FROM $6.75 - Bitget
Truist Securities Adjusts Price Target on Astrana Health to $55 From $47, Keeps Buy Rating - marketscreener.com
Astrana Health Inc. (ASTH) Stock Analysis: Exploring A 34.77% Potential Upside - DirectorsTalk Interviews
Astrana Health Submits Q2 2026 SEC Form 10-Q Detailing Financials and Share Information - Kalkine Media
Astrana Health, Inc. Q2 2026: Revenue $972.5M, EPS $0.4— 10-Q Summary - TradingView
Astrana Health (ASTH) grows Q2 2026 revenue to $972.5M with stronger profit - stocktitan.net
Results: Astrana Health, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts - 富途牛牛
Employment Law Attorneys, at Blumenthal Nordrehaug Bhowmik De Blouw LLP, Filed a Lawsuit Against Astrana Health Management, Inc., for Alleged Violations of Meal & Rest Period Requirements - PR Newswire
Sei Investments Co. Raises Stake in Astrana Health, Inc. $ASTH - MarketBeat
Barclays Sticks to Their Buy Rating for Astrana Health (ASTH) - The Globe and Mail
Astrana Health (NASDAQ:ASTH) Raised to Buy at Wall Street Zen - MarketBeat
Astrana Health (ASTH) Stock Rises On Cash Flow Strength And Deleveraging - simplywall.st
Astrana Health Inc. Stock 12‑Month Price Target Raised to $50.5, Implies 48% Upside - TradingView
Truist Financial Maintains Astrana Health(ASTH.US) With Buy Rating - Moomoo
A Quick Look at Today's Ratings for Astrana Health(ASTH.US), With a Forecast Between $41 to $53 - Moomoo
Earnings call transcript: Astrana Health tops Q2 2026 profit forecasts By Investing.com - Investing.com Nigeria
Astrana Health (ASTH) Stock Sees Modest Fair Value Lift As Analysts Back Integration Progress - Yahoo Finance
Enterprise value to revenue forward of Astrana Health Inc. – FWB:3AM - TradingView
Astrana Health (ASTH) Surges 5.22% as Momentum Builds Toward Key ResistanceComposite Profile - Vinanet
ASTH Q2 Deep Dive: AI-Driven Operating Leverage and Strategic Expansion Shape Outlook - The Globe and Mail
Astrana Health beats EPS estimates, raises EBITDA guidance By Investing.com - Investing.com Nigeria
Astrana Health, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Astrana Health, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:ASTH) 2026-08-06 - Seeking Alpha
Earnings call transcript: Astrana Health tops Q2 2026 profit forecasts - Investing.com
Astrana Health Q2 Earnings Call Highlights - MarketBeat
ASTH Looks 59.4% Undervalued on GF Value™ - GuruFocus
Astrana Health, Inc. (ASTH) Q2 Earnings Top Estimates - Yahoo Finance
ASTRANA HEALTH ($ASTH) Releases Q2 2026 Earnings - Quiver Quantitative
Earnings Flash (ASTH) Astrana Health, Inc. Posts Q2 Adjusted EPS $0.80 per Share, vs. FactSet Est of $0.79 - marketscreener.com
Earnings Flash (ASTH) Astrana Health, Inc. Reports Q2 Revenue $972.5M, vs. FactSet Est of $985.6M - marketscreener.com
(ASTH) Astrana Health, Inc. Expects Q3 Revenue Range $1.00B$1.03B - marketscreener.com
Astrana Health (NASDAQ:ASTH) Beats Q2 CY2026 Non-GAAP EPS Estimates, Stock Soars 5.1% - Barchart.com
Astrana Health, Inc. Reports Second Quarter 2026 Results - PR Newswire
Astrana Health Inc (ASTH) 財務データ
収益
当期純利益
現金流量
EPS
Astrana Health Inc (ASTH) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Sim Brandon | CEO and President |
Feb 02 '26 |
Option Exercise |
23.24 |
21,334 |
495,802 |
1,045,329 |
| Schmidt David | Director |
Jan 13 '26 |
Option Exercise |
5.79 |
20,000 |
115,800 |
35,763 |
| Lam Thomas S. | Director |
Dec 08 '25 |
Option Exercise |
17.78 |
29,502 |
524,546 |
459,122 |
| Sim Kenneth T. | Executive Chairman |
Nov 10 '25 |
Option Exercise |
17.78 |
29,502 |
524,546 |
639,407 |
| Kitayama Mitchell W | Director |
Nov 07 '25 |
Option Exercise |
18.20 |
12,000 |
218,400 |
27,846 |
| Mazdyasni Matthew | Director |
Nov 10 '25 |
Option Exercise |
18.20 |
20,000 |
364,000 |
34,763 |
| Marsh Linda | Director |
Nov 03 '25 |
Option Exercise |
18.20 |
20,000 |
364,000 |
103,641 |
| Kitayama Mitchell W | Director |
Sep 15 '25 |
Option Exercise |
18.20 |
8,000 |
145,600 |
29,060 |
| Schmidt David | Director |
Sep 02 '25 |
Option Exercise |
18.20 |
20,000 |
364,000 |
35,763 |
0.51%
0.28%
大文字化:
|
ボリューム (24 時間):